Diagnostics and Resistance Profiling of Bacterial Pathogens

Area of Science:

• Infectious Diseases
• Microbiology
• Biomarker Discovery

Background:

• Infectious diseases remain a leading cause of death globally, with outcomes unchanged despite healthcare advances.
• Increasing antibiotic resistance complicates treatment, leading to higher mortality and significant financial burdens.
• The rise of multidrug-resistant organisms presents a major diagnostic and therapeutic challenge to modern medicine.

Purpose of the Study:

• To highlight the urgent need for optimized diagnostics, therapies, and prevention strategies for infectious diseases.
• To explore the potential of -omics technologies in identifying biomarkers for infectious diseases.
• To discuss the transformative impact of molecular diagnostics on combating antibiotic resistance.

Main Methods:

• Review of current challenges in infectious disease diagnosis and treatment.
• Exploration of the application of -omics technologies (genomics, transcriptomics, proteomics, metabolomics) for biomarker discovery.
• Discussion of the potential of molecular test systems for pathogen identification and resistance profiling.

Main Results:

• -Omics technologies have advanced the identification of biomarkers for infectious diseases.
• Biomarker-driven molecular tests are expected to revolutionize infectious disease diagnostics.
• Molecular tests can accelerate pathogen identification and antibiotic resistance profiling.

Conclusions:

• Molecular diagnostic systems offer a future for prompt, targeted therapy and effective antibiotic stewardship.
• Replacing traditional culturing with molecular tests will reduce the spread of multidrug resistance.
• Early diagnosis via molecular tests is crucial for combating antibiotic resistance and preventing new resistance emergence.